Forest Labs (FRX) Extends Deadline for Acquisition of Clinical Data (CLDA); Amends Merger Agreement
Down)
Forest Laboratories, Inc. (NYSE: FRX) has extended its tender offer for the acquisition of Clinical Data, Inc. (Nasdaq: CLDA).
Additionally, Forest announced that it has amended its Merger Agreement. Click here for more color from the release.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Additionally, Forest announced that it has amended its Merger Agreement. Click here for more color from the release.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Delphi Automotive (DLPH) in Talks with FCI to Buy Motorized Vehicles Unit
- BlackRock (BLK) Substantially Boosts Stake in Chesapeake (CHK) -CNBC's Kelly
- Citi (C) selling stake in Turkey's Akbank, valued at $1.27B -Bloomberg
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Forest Laboratories/Clinical DataSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
